SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-17-004447
Filing Date
2017-07-28
Accepted
2017-07-28 16:06:09
Documents
64
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_072817p.htm 10-Q 355192
2 EXHIBIT 31.1 exh_311.htm EX-31.1 7915
3 EXHIBIT 31.2 exh_312.htm EX-31.2 7950
4 EXHIBIT 32.1 exh_321.htm EX-32.1 2988
  Complete submission text file 0001171843-17-004447.txt   2849882

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE anik-20170630.xml EX-101.INS 485406
6 XBRL SCHEMA FILE anik-20170630.xsd EX-101.SCH 45035
7 XBRL CALCULATION FILE anik-20170630_cal.xml EX-101.CAL 35996
8 XBRL DEFINITION FILE anik-20170630_def.xml EX-101.DEF 282997
9 XBRL LABEL FILE anik-20170630_lab.xml EX-101.LAB 226869
10 XBRL PRESENTATION FILE anik-20170630_pre.xml EX-101.PRE 299891
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14027 | Film No.: 17990049
SIC: 3841 Surgical & Medical Instruments & Apparatus
Industrial Applications and Services